Monday 02 November 2020

RDJ advises Solvotrin Therapeutics on €6.7m financing

Ronan Daly Jermyn (RDJ) advised Solvotrin Therapeutics on its recent €6.7m financing by London-based RAB Capital and existing investor Elkstone Ventures.

The Cork-based healthcare company manufactures a number of ‘active iron’ products. The group’s supplements are currently sold in a number of EU countries, the US, China, and New Zealand, as well as globally through Amazon.

The company said its new funding will be used to support expansion in international markets including the US, China, India and the Middle East.

Gillian KeatingJohn CuddiganMarie Gavin and Kate Murphy advised on the transaction.

Letter footer for printed documents
© 2022 Ronan Daly Jermyn
Web design by Granite Digital
Sign up to our newsletter
RDJ logo

We're hiring
Join RDJ

Find out more